Dan Sarkin

Dan’s representative matters prior to and since joining Kirkland & Ellis have included advising:

• Thoma Bravo on the investment in LOGEX, a leading healthcare analytics provider and the inaugural investment by Thoma Bravo’s Europe-based team.
• Antin Infrastructure Partners on its acquisition of Wildstone.
• Recipharm, a portfolio company of EQT, on the acquisitions of Arranta Bio, a prominent advanced therapy CDMO, and Vibalogics, a virotherapy CDMO.
• Apex Fund Management, a portfolio company of TA Associates and Genstar, on the acquisition of the Maitland fund services business. 
• Thoma Bravo on the strategic investment in Condeco, a global leader in workspace scheduling technology. 
• Blackstone and Brown Bidco Limited on the $4.73 billion recommended take private of Signature Aviation.
• EQT VI on the sale of Anticimex, a global pest control specialist. 
• E2Open on the $1.7 billion acquisition of BluJay Solutions, a leading international cloud-based, logistics execution platform.
• AJAX I on its $7 billion business combination with Cazoo Holdings Limited.
• TDR Capital on the acquisition of BPP, a global leader in professional and vocational education.
• A private Qatari investor on the acquisition of The Ritz.
• A private equity fund on the sale of a renowned British publishing company.
• A private investor on the sale of a London hotel group.

Macfarlanes LLP

• Solicitor (2020–2021)
• Trainee Solicitor (2018–2020)